CAY10462, the HCl salt of CAY10434, is a selective inhibitor of 20-HETE synthase CYP4A11 with IC50 of 8.8 nM when tested in human kidney microsomes. 4 CAY10434 is almost 200-fold less potent as a 1A, 1C, and 3A CYP450 inhibitor.

Physicochemical Properties

Molecular Formula	C17H27CL2N3O
Molecular Weight	360.323
Exact Mass	359.153
Elemental Analysis	C, 56.67; H, 7.55; Cl, 19.68; N, 11.66; O, 4.44
CAS #	502656-68-0
Related CAS #	CAY 10434;769917-29-5
PubChem CID	71433756
Appearance	Off-white to light yellow solid powder
LogP	4.977
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	9
Heavy Atom Count	23
Complexity	265
Defined Atom Stereocenter Count	0
InChi Key	SRCWAJONAASSNJ-UHFFFAOYSA-N
InChi Code	InChI=1S/C17H25N3O.2ClH/c1-19(2)12-5-3-4-6-14-21-17-9-7-16(8-10-17)20-13-11-18-15-20;;/h7-11,13,15H,3-6,12,14H2,1-2H3;2*1H
Chemical Name	1-Hexanamine, 6-[4-(1H-imidazol-1-yl)phenoxy]-N,N-dimethyl-, hydrochloride (1:2)
Synonyms	769917-29-5 (free base), 502656-68-0 (HCl),
HS Tariff Code	2934.99.9001
Storage	Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition	Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity

ln Vitro	The buildup of angiotensin II in endothelium intact aortic rings is increased when miconazole and CAY 10434 dihydrochloride (1 µM; 30 minutes) are combined [1].
References	[1]. 17-Octadecynoic acid improves contractile response to angiotensin II by releasing vasocontrictor prostaglandins. Prostaglandins Other Lipid Mediat. 2012 Jan;97(1-2):36-42.

Solubility Data

Solubility (In Vitro)

DMSO : ~35.71 mg/mL (~99.11 mM)

Solubility (In Vivo)

Solubility in Formulation 1: ≥ 2.08 mg/mL (5.77 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (5.77 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.)

Preparing Stock Solutions		1 mg	5 mg	10 mg
	1 mM	2.7753 mL	13.8766 mL	27.7531 mL
	5 mM	0.5551 mL	2.7753 mL	5.5506 mL
	10 mM	0.2775 mL	1.3877 mL	2.7753 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.